Professor of Oncology, Angus Dalgleish gives vital information on a repurposed drug he uses for his cancer patients, given at a very low dose. This is Low Dose Naltrexone.



Check out the LDN trust website for much more, https://ldnresearchtrust.org



Naltrexone at low doses (LDN) and its relevance to cancer therapy